Loading…
Start stopping smartly
The meeting was part of the academy's wider ongoing inquiry into how we can all best use evidence to judge the benefits and harms of treatments, which was prompted by concerns about loss of trust in research and medicine (doi: 10.1136/bmj.h3300 ), with a specific focus on several BMJ investigat...
Saved in:
Published in: | BMJ (Online) 2016-06, Vol.353, p.i3209 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The meeting was part of the academy's wider ongoing inquiry into how we can all best use evidence to judge the benefits and harms of treatments, which was prompted by concerns about loss of trust in research and medicine (doi: 10.1136/bmj.h3300 ), with a specific focus on several BMJ investigations and campaigns: tamiflu, statins, and conflicts of interest ( www.bmj.com/campaigns ). |
---|---|
ISSN: | 1756-1833 1756-1833 |
DOI: | 10.1136/bmj.i3209 |